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Introduction
Oral anticoagulant therapy effectively prevents thromboem-
bolism and its major complication is hemorrhage. The
majority of life-threatening hemorrhagic events associated
with warfarin use consists of intracranial, intraabdominal and
most frequently, gastrointestinal bleeding (1,2). Hemorrhagic
complications have been identified in soft tissue (including
wounds, 21%), gastrointestinal tract (15%), urinary tract
(15%), nose and pharynx (35%), intracranial (4%), thorax
(3%), joints (0.5%), intraocular (2%), and retroperitoneum
(1%) (1).
We describe a patient with warfarin toxicity suffering from
hypovolemic shock due to a large hematoma in his back.
Although there are a large number of patients with
hematomae in soft tissues, the specific location of the present
case resulting in shock is unique and worth reporting.
Case report
A forty-eight year-old man was brought to the Emergency
Department (ED) by his wife due to malaise and a history of
near-syncope. He appeared sweaty and pale with a blood
pressure of 90/65 mm Hg, heart rate 109 beats/minute, and
respiratory rate 28 breaths/minute.
According to his wife, he had taking warfarin (Coumadine) 5
mg tablets after aortic valve replacement for nearly six months.
Upon awakening one morning, he had a visible lump in his left
back region, he was very pale, and complained of dizziness,
lightheadedness and blackouts. He reported that the mass in his
back was enlarging and he had a near-syncope episode en route
to the hospital. The patient and his wife denied any direct injury,
hit, or fall that could result in the mass recently.
Physical examination disclosed a pale and ill-appearing
patient with a 18 x 13 cm lump in his back from left thorax to
lumbar area (Fig. 1a-b). There was no skin discoloration over
the lump, which was tender on palpation. Digital rectal exam-
ination was negative for occult or gross blood and there was
nothing remarkable on the examination of other systems.
Laboratory examination revealed hemoglobin (Hg) 8.9 g/dL,
hematocrit (Htc) 23.5%, prothrombin time (PT) >140 sec,
activated partial thromboplastin time (aPTT) >140 sec,
international normalized ratio (INR) 12. Values recorded one
month before were Hg 15.1 g/dL, Htc 31.7 %, INR 2.6.
His ECG was not remarkable in terms of ischemic or arrhyth-
mic findings. There was no sign or finding suggestive of
cardiogenic shock.
Thoracoabdominal computed tomography revealed a large
hematoma with a thickness of 5 cm in thoracic sections, and a
craniocaudal length of 20 cm between intercostal muscles
and serratus anterior and latissimus muscles, reaching into
subcutaneous fat tissue just lateral to abdominal oblique
muscles (Fig. 2a-c).
The patient was treated with 2 L normal saline in two
hours in the ED. Additionally, four units of fresh frozen
plasma and two units of erythrocyte suspension were given,
and intravenous menadione sodium bisulphate (vitamin K)
40 mg was administered (phytonadione was not available).
Use of recombinant factor VIIa was reserved in case of fail-
ure of improvement. The course of his coagulation profile
and complete blood count is depicted in Table 1.
He was admitted into the Intensive Care Unit run by cardi-
ologists where he received additional two units of erythrocyte
suspension. The patient was then followed on the ward for
26 days in order to ensure that the bulk of clot was com-
pletely resolved. His lump resolved in the meantime with no
adverse events. The patient was informed and educated on
side and untoward effects of warfarin treatment and was dis-
charged with recommendations. The lump in his back was
Received 26 June 2007; accepted 20 August 2007.
Address correspondence to Mustafa Serinken, M.D., Pamukkale
University Medical School, Dept. of Emergency Medicine, 20070,
Denizli-Turkey. E-mail: mserinken@hotmail.com
Clinical Toxicology vol. 46 no. 8 2008
766 M. Serinken et al.
completely resolved in his follow-up visit one month later
and his coagulation profile was within acceptable limits.
Discussion
Anticoagulant agents are nowadays used commonly to pre-
vent acute ischemic stroke, deep vein thrombosis, pulmonary
embolism, in the setting of acute myocardial infarction, atrial
fibrillation, and valvular heart diseases. Warfarin is the most
commonly prescribed member of the family. Untoward con-
sequences attributed to Warfarin are not infrequent in the
routine medical practice. Bleeding is the most significant
adverse event (1).
Major bleeding episodes are reported to occur in 1 to 12%
of cases (3) while a similar study cited the rate as 3% (1). The
rate of major bleeding in Turkey was reported as 21.6% (4).
The authors commented the high incidence of major bleeding
episodes in Turkey could be attributed to social and cultural
diversity, difficulties in follow-up of bleeding profiles and
genetic factors (4,5). For example, it is somehow more diffi-
cult in our country to reach the physician following the
patient, or to get an outpatient follow-up date to have the
prothrombin time checked.
Gastrointestinal bleeding comprises the major part of
major bleeding episodes attributed to warfarin toxicity (2). A
literature search revealed that few reports were available
regarding nontraumatic hemorrhages sparing gastrointestinal
system due to warfarin toxicity; most of these data were
based on retroperitoneal intraabdominal hemorrhages (6–10).
Two cases were reported to suffer from intramuscular
hemorrhage resulting in hemodynamic instability hemor-
rhagic shock in the course of warfarin toxicity (6,11).
Hematomas were noted in the anterior wall of abdomen and
there were apparent masses on examination and hypovolemic
shock in both cases. On the other hand, a hematoma emerged
in and around serratus anterior muscle in the back, enlarged
and descended into lumbar area in the present case. The
hemorrhage resulted in hemorrhagic shock due to a large
abdominal wall hematomas. This specific location is unique
in the literature.
Symptoms emerged with a simple lump that developed
into a mass, sweating, dizziness, lightheadedness, and black-
outs and near-syncope associated with on-going hemorrhage.
Physicians in the EDs and primary care institutions need to
consider bleeding intramuscularly in the abdominal wall and
back in the setting of warfarin toxicity among usual causes of
hemorrhagic shock. A rapid inspection can overlook these
unusual localizations of bleeding episodes. Efficient, aggres-
sive treatment must be instituted before the hemorrhage give
way to apparent hypovolemic shock.
Fig. 1. a-b. Painless mass in the left thoracolumbar area.
Fig. 2. a-c. Thoracic and abdominal CT images. Coronal reconstructed images (a, b), and axial CT image (c). Hypodense hematoma can be
imaged in the left hemithorax between intercostal muscles and serratus anterior muscles, lateral to oblique abdominal muscles reaching to
subcutaneous fat tissue.
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Conclusion
Bleeding episodes associated with warfarin overdose result-
ing in shock states are not always detected in gastrointestinal
tract and in intraabdominal area. ED and primary care physi-
cians should never overlook major hemorrhagic complica-
tions occurring in unusual locations.
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Table 1. The course of the patient’s coagulation profile and
complete blood count
Time Hg (g/dL) Htc (%) PT (sec) aPTT (sec) INR
Admission 8,9 23,5 140> 140> 12,4
5 hr 9,3 28,0 42,8 62,1 4,36
10 hr 10,0 29,6 30,2 44,9 2,79
24 hr 11,8 36,0 13,2 27,4 1,02
Hg: Haemoglobin Htc: haematocrit hr: hours.
